Association between blood methylmalonic acid and chronic kidney disease in the general US population: insights from multi-cycle National Health and Nutrition Examination Survey (NHANES)
Annals of Translational Medicine · 2024-06 · 12 (3) · 47-47
DOI: 10.21037/atm-23-1930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Translational Medicine, 2024-06. Verfasst von Liang Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) is significantly influenced by mitochondrial dysfunction (MD). Previous research suggests that methylmalonic acid (MMA) is involved in MD. Consequently, we aimed to investigate associations between blood MMA level and the prevalence of CKD as well as mortality in patients with CKD.
Methods
The study included 23,587 individuals from National Health and Nutrition Examination Survey (NHANES). The NHANES datasets from 1999-2004 and 2011-2014 were utilized as separate primary and validation subsets. There were 3,554 patients with CKD. The association of blood MMA level with the prevalence of CKD was investigated using weighted logistic regression. Meanwhile, we employed weighted Cox regression models to evaluate the association between blood MMA level and all-cause mortality in patients with CKD.
Results
Blood MMA levels had a significant positive association with urinary albumin-to-creatinine ratio (β=45.29, P=0.01) and negative association with estimated glomerular filtration rate (β=-15.27, P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
- Institute of Nephrology, Peking University, Beijing, China.
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
- Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
- Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong, China.
Zitieren
APA
Wu, L., Chang, D. Y., Zhao, M. H., Tang, S. C. W., & Chen, M. (2024). Association between blood methylmalonic acid and chronic kidney disease in the general US population: insights from multi-cycle National Health and Nutrition Examination Survey (NHANES). Annals of Translational Medicine, 12(3), 47-47. https://doi.org/10.21037/atm-23-1930
Vancouver
Wu L, Chang DY, Zhao MH, Tang SCW, Chen M. Association between blood methylmalonic acid and chronic kidney disease in the general US population: insights from multi-cycle National Health and Nutrition Examination Survey (NHANES). Annals of Translational Medicine. 2024;12(3):47-47. doi:10.21037/atm-23-1930
BibTeX
@article{Wu2024,
author = {Wu, Liang and Chang, Dong-Yuan and Zhao, Ming-Hui and Tang, Sydney C W and Chen, Min},
title = {Association between blood methylmalonic acid and chronic kidney disease in the general US population: insights from multi-cycle National Health and Nutrition Examination Survey (NHANES)},
journal = {Annals of Translational Medicine},
year = {2024},
volume = {12},
number = {3},
pages = {47--47},
doi = {10.21037/atm-23-1930}
}
EUVIMED